“Neurological manifestations of COVID-19” - guideline of the German society of neurology

被引：0
作者：
Peter Berlit
Julian Bösel
Georg Gahn
Stefan Isenmann
Sven G. Meuth
Christian H. Nolte
Marc Pawlitzki
Felix Rosenow
Benedikt Schoser
Götz Thomalla
Thomas Hummel
机构：
[1] Secretary General of the German Society of Neurology,Department of Neurology
[2] Klinikum Kassel,Department of Neurology
[3] DGNI,Department of Neurology and Clinical Neurophysiology
[4] Klinikum Karlsruhe,Department of Neurology
[5] DGNI,Department of Neurology with Institute for Translational Neurology
[6] St. Josef Hospital Moers,Epilepsy Center Frankfurt Rhein
[7] University Hospital Düsseldorf,Main, Center of Neurology and Neurosurgery
[8] Department of Neurology with Experimental Neurology and Center for Stroke Research Berlin (CSB) Charité-University Berlin,Friedrich Baur Institute at the Neurological Department
[9] University Hospital Münster,Department of Neurology, Head and Neurocenter
[10] University Hospital Frankfurt,Interdisciplinary Center for Smelling and Tasting, University ENT Hospital Dresden
[11] LM-University Munich,undefined
[12] University Hospital Hamburg-Eppendorf,undefined
[13] German Society for ENT Medicine,undefined
来源：
Neurological Research and Practice | / 2卷
关键词：
SARS-CoV-2; COVID-19; Anosmia; Hyposmia; Encephalopathy; Encephalitis; Epileptic seizures; Seizure recurrence; Meningoencephalitis; Myelitis; Encephalomyelitis; Neuromuscular diseases; Myositis; Myasthenia gravis; Guillain-Barré syndrome; Miller Fisher syndrome; Critical illness weakness; Critical illness neuropathy/myopathy; Intensive care unit acquired weakness; ECMO; Ventilation; Delirium; Status epilepticus; Stroke; Intracerebral hemorrhage; Intracranial hemorrhage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a previously unknown clinical picture, which is known as COVID-19 (COrona VIrus Disease-2019) and was first described in the Hubei region of China. The SARS-CoV-2 pandemic has implications for all areas of medicine. It directly and indirectly affects the care of neurological diseases. SARS-CoV-2 infection may be associated with an increased incidence of neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia and neuromuscular diseases.
引用
收藏
相关论文
共 254 条
[31]  
Rafai MA(2020)Keeping people with epilepsy safe during the Covid pandemic Neurology 94 e49-9
[32]  
El Benna N(2020)Frequent convulsive seizures in an adult patient with COVID-19: A case report Iranian Red Crescent Medical Journal 22 109-9
[33]  
El Kettani C(2020)New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study Epilepsia. 61 557-502
[34]  
Soussi M(2020)Focal status epilepticus as unique clinical feature of COVID-19: A case report Seizure. 78 1-369
[35]  
Gutierrez-Ortiz C(2005)The impact of SARS on epilepsy: The experience of drug withdrawal in epileptic patients Seizure. 14 1787-422
[36]  
Mendez A(2017)Position paper on olfactory dysfunction Rhinology Supplement 25 135-269
[37]  
Rodrigo-Rey S(1930)Anosmie und Influenza (Ein rhinologischer Beitrag zur Differentialdiagnose der Erkältungskrankheiten) Medizinische Klinik 48 277-1069
[38]  
San Pedro-Murillo E(2006)Post-infectious olfactory dysfunction exhibits a seasonal pattern Rhinology 44 1-1720
[39]  
Bermejo-Guerrero L(2015)The olfactory nerve: A shortcut for influenza and other viral diseases into the central nervous system The Journal of Pathology 235 1-1062
[40]  
Gordo-Manas R(2020)Neurologic manifestations of hospitalized patients With coronavirus disease 2019 in Wuhan, China [published online ahead of print, 2020 Apr 10] JAMA Neurology 77 489-384
12345678910